IMPORTANCE Recent genome-wide association studies (GWAS) and pathway analyses supported long-standing observations of an association between immune-mediated diseases and Parkinson disease (PD). The post-GWAS era provides an opportunity for cross-phenotype analyses between different complex phenotypes.
studied types of autoimmune disorders were identified with an increased risk of developing PD, including amyotrophic lateral sclerosis, hyperthyroidism, hypothyroidism, multiple sclerosis, pernicious anemia, and polymyalgia rheumatica, although this finding was not observed in a population-based casecontrol study 13 from Denmark. The association between PD and MS has been confirmed in other studies. [14] [15] [16] Furthermore, in clinical studies, 17, 18 regular users of nonsteroidal antiinflammatory drugs were found to have lowered risk of PD. It is still not clear whether immune dysfunction has an important role in early stages of PD or is simply the end product of a neuronal degeneration process. 19 The occurrence of PD in patients with autoimmune diseases, or vice versa, could reflect genetically determined factors influencing both lipid metabolism and immune disorders that cannot be elucidated by epidemiological and clinical studies alone. 19 Genome-wide-based pathway analyses in PD supported the association between PD and autoimmune diseases. 5 Early independent studies showed that at least one gene, LRRK2, is statistically significant in both PD 20 and Crohn disease. 21 The results of a recently published study 22 suggested that, along with known PD loci USP25, HLA-DRA, and LRRK2, additional genetic factors are present that contribute to genetic comorbidity shared by PD and CD. A systematic study is needed to decipher whether shared polygenetic risk variants (ie, genetic pleiotropy) exist between PD and autoimmune diseases and whether particular molecular biological pathways are involved. An approach combining GWAS data from 2 disorders with shared pathways can significantly increase the power to discover novel loci and partly reveal the missing heritability in GWAS. Our group recently developed a novel statistical framework to identify single-nucleotide polymorphisms (SNPs) exhibiting genetic pleiotropy between multiple phenotypes and applied it to identify pleiotropy between AD and autoimmune diseases. 23 This approach also identified novel loci between schizophrenia and cardiovascular diseases, 24 psychiatric disorders, 25 and neurological diseases. 26 Herein, we applied this approach to investigate the potentially shared genetic basis for PD and autoimmune diseases. Autoimmune diseases were selected based on available large GWAS, including PD, type 1 diabetes, CD, ulcerative colitis, rheumatoid arthritis celiac disease, psoriasis, and multiple sclerosis. [27] [28] [29] [30] [31] [32] [33] We used conditional and conjunction false discovery rate analyses to define SNPs associated with both groups of phenotypes (pleiotropic SNPs).
Methods

Participant Samples
Using the conjunction false discovery rate method, this study analyzed GWAS data from a selection of archetypal autoimmune diseases among 138 511 individuals of European ancestry and systemically investigated pleiotropy between PD and type 1 diabetes, Crohn disease, ulcerative colitis, RA, celiac disease, psoriasis, and multiple sclerosis. Genome-wide association studies summary statistic P values and z scores were obtained from the studies of PD, 4 33 (eTable 1 in the Supplement). Details of the inclusion criteria and phenotype characteristics of the GWAS are described in the original publications. The relevant institutional review boards or ethics committees approved the research protocol of the individual GWAS used in the present analysis, and all participants gave written informed consent.
The dates of the analysis were June 10, 2015, to March 4, 2017.
All P values were corrected for inflation using a genomic control procedure.
24,25
Statistical Analysis
Conditional Quantile-Quantile Plots
The quantitative estimates of true associations and statistical enrichment were calculated from the distributions of summary statistics. 34 , 35 We plotted conditional quantile-quantile (Q-Q) plots for a primary phenotype by filtering SNPs based on their level of association with a secondary phenotype. Pleiotropic enrichment between PD and an autoimmune disorder was evident if the degree of deflection of PD P values from the expected null line produced successive leftward deflection when conditioned on an autoimmune disease. 24, 25, 36 To control for linkage disequilibrium (LD), we performed a random pruning procedure.
Conditional and Conjunction False Discovery Rate
We defined conditional false discovery rate, denoted by FDR trait1|trait2 , as the posterior probability that a given SNP is null for the first trait given that the P values in both traits are smaller than their observed P values. 24 , 25 We defined conjunction false discovery rate, denoted by FDR trait1&trait2 , as the posterior probability that a given SNP is null for both phenotypes simultaneously given that the P values for both traits are as small or smaller than the observed P values. We obtained a conservative estimate of conjunction false discovery rate by taking the minimum of FDR trait1|trait2 and FDR trait2|trait1 . To control for LD, we applied a random pruning procedure. 37 Detailed information on the methods can be found in prior studies.
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NeuroX Data We replicated the top conjunction false discovery rate loci, highly associated with both PD and autoimmune disorders, in a second independent PD data set. The data set was generated with the NeuroX exome array, 3, 38 including 6927 PD cases and 6108 controls. Variants passing standard quality control (Hardy-Weinberg equilibrium P >1×10 −6 and maximum missingness rate of 5%) were tested for association with PD with a logistic model correcting for the first 4 multidimensional scaling components and sex.
Gene Expression and Methylation Changes
We determined the regional methylation and expression patterns within ±1 megabases of 103 SNPs of interest. We investigated frontal cortex and cerebellum microarray data from the North American Brain Expression Consortium (NABEC) 39 
Genetic Correlations Among Implicated Loci
To investigate the genetic relatedness among implicated SNPs, we performed protein-protein interaction analyses using STRING version 10. 42 The input consisted of novel loci as identified in pleiotropic analyses. We considered total scores above 0.400 (medium confidence) that correspond to the combination of the following 4 different scores: coexpression, experimental, knowledge, and text mining.
Results
Significant Genetic Overlap Between PD and Autoimmune Diseases
Conditional Q-Q plots for PD conditioned on association P values of autoimmune diseases showed strong enrichment for Crohn disease ( Figure 1 ). Successive leftward shifts for decreasing nominal PD P values indicated that the proportion of non-null SNPs in PD increased considerably with higher levels of association with an autoimmune phenotype. For example, when conditioned on CD, the proportion of SNPs reaching a significance of PD P <10 −5 in the category Crohn disease P <10 −3 is 20 times greater than when all SNPs were examined ( Figure 1 and eFigure 1 in the Supplement). Similar enrichment was found with ulcerative colitis and RA, and weaker , and P <10 −3 . All P values have been corrected for genomic inflation. Dotted lines indicate the expected line under the null hypothesis, and leftward deflection shows increasing degrees of enrichment.
enrichment was found with celiac disease and multiple sclerosis. The enrichment remained after removing the major histocompatibility complex and MAPT regions (eFigure 2 in the Supplement).
Shared Susceptibility Loci for PD and Autoimmune Disorders
We performed a conjunction false discovery rate analysis and visualized the pleiotropic loci between PD and autoimmune diseases in a Manhattan plot (Figure 2 ). Based on conjunction false discovery rate less than 0.05, we detected 17 independent pleiotropic loci for the 7 autoimmune diseases ( Table 1) . Nine loci remained after excluding the major histocompatibility complex and MAPT regions (eTable 2 in the Supplement). Of the 17 loci, the directions of PD effect given by z scores were mostly the same with Crohn disease, ulcerative colitis, and celiac disease and opposite with rheumatoid arthritisand psoriasis (Table 1 and eTable  3intheSupplement ). The conjunction false discovery rate analyses over multiple autoimmune phenotypes showed overlapping susceptibility loci between Crohn disease and ulcerative colitis and demonstrated some overlap between ulcerative colitis, RA, celiac disease, and multiple sclerosis (eFigure 3 in the Supplement). We were able to replicate 5 loci in our in-house independent NeuroX data at P < .05 (Table 1 ). In addition to the previously published HLA, LRRK2, and MAPT associations, 4 we also identified 2 new loci adjacently located to TRIM10 and SETD1A.
Functional Interpretation of Shared Susceptibility Loci
A total of 103 associated variants resulting from conditional false discovery rate less than 0.01 and conjunction false discovery rate less than 0.05 were tested for being a methylation QTL (methQTL) or an eQTL. 4 These SNPs could contribute to PD risk through immune mechanisms by regulating the gene expression of these PD-related genes in these immune-specific cells. Six immune eQTL that regulate the expression of 2 genes (DGKQ and DMPK) were also observed in the brain eQTL and methQTL data, affirming the immune-related involvement of these genes in PD.
Shared Biological Pathways Between Significant Risk Loci
Using functional gene networks and protein interaction networks, the connectivity among the loci in the combined network increased considerably compared with the networks represented by pleiotropic and PD loci ( Figure 3) . The network analyses revealed interaction between the 17 loci identified in our study with nodes defined by PD loci (eg, GUCY1A3, KANSL1, CRHR1, WNT3, and BOLA2). This finding phenotypes, as well as the minimum conjunction FDR across all phenotypes. One SNP is listed for the major histocompatibility complex region on chromosome 6. Nine of the top loci were available for association testing within the NeuroX data set. Meta-analysis association P values in the study by Nalls et al 3 were obtained from publicly available PDGene (pdgene.org). Abbreviations: CAGE, cap analysis gene expression; CpG, methylation assay; eQTL C, eQTL assay based on CAGE expression data; eQTL M, eQTL assay based on microarray expression data; maf, minor allele frequency; SNP, single-nucleotide polymorphism; Trait, probe name of methylation or expression assay.
a In North American Brain Expression Consortium (NABEC), United Kingdom Brain Expression Consortium (UKBEC), or CAGE data set.
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demonstrates biological relatedness between the pleiotropic loci from the present analysis and PD loci from previous reports.
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Discussion
Genetic comorbidities between PD and immune-related genes have only been explored for high-risk PD loci. 5, 6, 22 Our study using a genome-wide unbiased statistical approach identified 17 shared loci between PD and 7 autoimmune diseases. This finding strengthens the hypothesis that known PD risk genes might contribute to PD through immune system defects (eg, LRRK2, GAK, HLA, and MAPT), 21, 48 while suggesting that additional loci with weaker associations also contribute to pleiotropy (Table 1) . TRIM10 is closely positioned to the HLA region, and, although not extensively described, variants in SETD1A have also previously been associated with PD. 49,50 While we found an overlap between genetic risk factors for autoimmune diseases and PD, the specific loci involved for each trait differed. This result is consistent with the findings that some susceptibility loci are associated with risk in multiple immune-mediated diseases.
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Because our method considers joint P values, some SNPs with strong association with PD might not pass the significance threshold if they only had marginal association with the autoimmune disease, and vice versa. For instance, a locus in SNCA has one of the strongest associations in PD 4 (PD P =3. 67×10 −26 ), but it is not associated with autoimmune diseases (RA P = .6184). Taking the 2 P values together, its conjunction false discovery rate is not significant (PD and rheumatoid arthritisconjunction false discovery rate of 0.9856). Among the 13 significant genes in our PD data set, 4 we did not find significant conjunction false discovery rate loci among SYT11, ACMSD, STK39, MCCC1/ LAMP3, BST1, SNCA, and CCDC62/HIP1R owing to weak association with autoimmune disorders (eTable 7 in the Supplement). Likewise, some known risk loci for immune diseases were not found in our results: one locus near CARD15/ NOD2 was significant in Crohn disease (P =1.21×10 −58 ) but not in PD (P = .2163), and its conjunction false discovery rate of 0.8496 did not pass our threshold. MC1R has been reported to be associated with PD and immune-mediated diseases, 52,53 but it had not been reported in our data sets of PD (P = .2936) or Crohn disease (P = .2936). Our brain-based QTL analyses suggest immune function-related genes for which the expression or methylation level is changed by of one of our identified susceptibility loci. Most of these genes are located in the HLA locus or MAPT locus, and owing to the complex underlying LD structures, it is difficult to define the true causal genes. However, our analyses implicate that, in addition to the PD-associated HLA genes and MAPT in these loci, TRIM31, CRHR1, PLEKHM1, and NSF might also be related to PD through defective components of the immune system. 54-56 For example, methylation levels of TRIM31 seem to be affected in the cerebellum by 2 susceptibility loci (rs9261531 and rs9261535)inTRIM10. It is hypothesized that TRIM family proteins are active in the innate immune response to intracellular infectious agents. 57, 58 In addition to known PD loci, there is one novel susceptibility locus that has an effect on methylation levels. This variant (rs7515174) is located in the third intron and affects the frontal cortex methylation state of FCGR2A. This gene encodes a protein belonging to the IgGFc receptor gene family in which the encoded proteins are located on the surface of many immune response cells and take part in clearing of immune complexes and phagocytosis. [59] [60] [61] Variants in FCGR2A have been associated with inflammatory bowel disease, Crohn disease, and ulcerative colitis, 62 and variants in other genes from the same family were associated with RA. 63 Of further interest are the 8 identified genes in which the expression is regulated by 10 pleiotropic SNPs (from 5 loci) in several specific immune cell types. 46 Five of the 8 genes are located in 3 loci previously associated with PD. 3 For example, SNCA expression is regulated by a pleiotropic variant (rs2736990)inin tron2of SNCA in monocytes. This finding seems in line with a previous study 64 describing an increase of monocytes in peripheral blood of patients with PD, implying an immune-related manifestation of PD through monocytes. RNPS1, DMPK, and DMWD (with the latter 2 genes involved in myotonic dystrophy 65 ) are 3 of the 8 immune-based eQTL that are newly associated with PD in the present study. The biologi- cal functions of these genes involve messenger RNA modification and intracellular trafficking or are unknown.
66,67
We used pathway analyses to discern the underlying relevant pathways; however, functional studies are pertinent to provide biological insight. Performing downstream pathogenetic analyses using cell-based models is beyond the scope of the present work. Nevertheless, we anticipate that the genetic loci highlighted in our study will motivate the scientific community to pursue this line of research.
The strong pleiotropic enrichment observed between PD and Crohn disease suggests a common pathogenetic link between these 2 phenotypes. Previous studies 21, 48 highlighted LRRK2 as a significant risk factor for both of these phenotypes. LRRK2 has been identified as having 2 independent Crohn disease risk loci (rs11564258 and rs3761863) 68 : only one of them is in high LD to our shared susceptibility locus rs17467164 (r 2 = 0.992 and r 2 = 0.075, respectively). The observed association between PD and Crohn disease indicates that defects in cargo transport mechanism might underline the disease pathogenesis in both phenotypes. 69 It is known that gastrointestinal tract dysfunction is associated with PD, perhaps even preceding the onset of central motor symptoms. 70 Several of the identified overlapping genes (CCNY, LRRK2, MAPT, RSPH6A, and SYMPK) are involved in basic cellular functions that may be related to alterations in enteric neurotransmission or intestinal motility disturbances. 71 Furthermore, the shared gene HLA-DQB1 has a central role in the immune system by introducing peptides derived from extracellular proteins, which implicate overlapping factors related to the immune system (CD4 T cells). We found moderate polygenic pleiotropic enrichment between PD and ulcerative colitis or RA, whereas genetic enrichment with type 1 diabetes, celiac disease, psoriasis, and multiple sclerosis was weak. In comparison, in a populationbased study, 13 the risk for PD was observed to increase in a subset of the cohort with autoimmune diseases and ulcerative colitis and to decrease in those with a previous diagnosis of RA. The epidemiological data in that investigation are in agreement with a recently published study 22 in which genetic comorbidities with PD were explored using top loci from diverse phenotypes. The authors observed a decreased risk for rheumatoid arthritisand psoriasis, but the findings were not statistically significant because of the small sample size. It is unlikely that patients with unrecognized immune-related disorders were included in the PD study 13 population in large enough numbers to affect the results; however, some participants in the autoimmune disorders population 13 could develop PD over time.
Inflammation of microglia, the major resident immune cells in the brain, 72 has been involved in degeneration of dopaminergic neurons affecting PD. 19, 73 The extent of genetic pleiotropy observed between PD and autoimmune diseases will help us to understand novel pathogenetic aspects of neurodegeneration in PD, a chronic immune activation of microglia, which may cause or contribute to degeneration of neurons. For example, it has been shown that aggregated α-synuclein protein (by overexpression of SNCA) activates the microglia, which increases nitration of α-synuclein and maintains the proinflammatory innate immune response in PD.
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In this context, the present findings of a polygenic link between PD and inflammatory biological function are likely to be relevant. Furthermore, recent evidence suggests that immune factors are also involved in other neurodegenerative diseases, such as AD. 23 
Limitations and Strengths
Our pleiotropy-based statistical framework was limited to GWAS with a high coverage of SNPs (>500 000); therefore, autoimmune disorders selected for this study were based on available GWAS data that fit these criteria. With more extensive GWAS data, it would be worthwhile to study a larger set of immune disorders associated with PD from epidemiological or clinical studies (eg, thyroid disease). 12 Our study is also limited in distinguishing between immune-mediated and autoimmune disease. It has been hypothesized that PD itself is an autoimmune disease. 75 Although we have shown herein using GWAS of autoimmune disorders that PD has a strong immune component, the conclusion of the hypothesis that PD is an autoimmune disease should be investigated through further cell-based functional studies. This work has clinical implications. Our data suggest more extensive clinical studies of patients with immunemediated disorders for PD signs to develop possible screening schemes for PD, and vice versa, for monitoring immune and inflammatory status among individuals with an increased risk for PD. 76 According to our study, apparently healthy individuals with a high load of these shared risk genotypes, predisposing them to inflammation disturbances, could be at particularly increased risk for developing PD. Further prospective studies in these individuals may clarify these issues. Our findings also suggest the need for further investigation of the role of immune-modulating agents in the treatment of PD. There is some evidence indicating that anti-immune drugs could be a viable option for therapeutic interventions in PD. A 2004 study 76 showed that candesartan cilexetil, a drug used for hypertension, reduces the α-synuclein-induced microglia phenotype. Therefore, data generated from our study may facilitate novel treatment strategies by increasing our understanding of the pathogenetic mechanisms influenced by pleiotropic disease loci.
Conclusions
In summary, our study highlights the usefulness of crossphenotype analyses to identify genetic overlap (ie, pleiotropic loci) between PD and a selection of autoimmune disorders. Our results suggest that these PD-associated loci contribute to PD through immune defects and that immune dysfunction is not simply the end product of the neurodegeneration process. The findings strongly support the presence of interaction between the immune system and neurodegeneration in PD. 
Statistical Analyses
Conditional Q Q Plots
The quantitative estimates of true associations and statistical enrichment were estimated from the distributions of summary statistics, 1,2 here visualized through Q Q plots of nominal p values in Figure 1 . To assess for genetic enrichment, we plotted conditional Q Q plots for a primary phenotype by creating subsets of SNPs based on the level of significance of each SNP's association with a secondary phenotype.
Pleiotropic enrichment between PD and an immune related disorder were evident if the degree of deflection of PD p values from the expected null line produced successive leftwards deflection based on conditioning with an immune related phenotype. 3 5 To control for Linkage Disequilibrium (LD), the analyses were performed using a random pruning procedure. 6 Due to the complex LD structure of the Major Histocompatibility Complex (MHC) and the MAPT region, we performed additional controls by removing these regions from the analysis.
Conditional and Conjunction FDR
Conditional FDR framework leveraged pleiotropic effects in the analysis of GWAS summary statistics, 3, 4 by incorporating the information on summary statistics of a second trait into the ranking of summary statistics from the first trait. We define the conditional FDR, denoted by FDR trait1|trait2 , as the posterior probability that a given SNP is null for the first trait, given that the p values for both traits are as small as or smaller than the observed p values. Detailed information on the formal definition and estimation are further described previously. 4 Conditional FDR was a better tool for investigating pleiotropic relationships than standard meta analysis, since it allowed the determination of the impact of the conditioning phenotype.
We extended our framework to a conjunction testing procedure named conjunction FDR. 3, 4 We defined conjunction FDR, denoted by FDR trait1&trait2 , as the posterior probability that a given SNP is non null for both phenotypes simultaneously, given the p values for both traits are as small or smaller than the observed p values. We obtained a conservative estimate of conjunction FDR by taking the minimum of FDR trait1|trait2 and FDR trait2|trait1 . Conjunction FDR allowed for identification of SNPs that are associated with both phenotypes, minimizing the identification of SNPs with a single phenotype driving the common association signal. We applied a random pruning procedure to control for LD. 6 © 2017 American Medical Association. All rights reserved.
To illustrate the localization of the pleiotropic genetic markers association with both PD and immune mediated diseases, we used a 'Conjunction FDR Manhattan plot' in Figure 2 , showing all SNPs with a significant conjunction FDR within an LD block in relation to their chromosomal location. We ranked all SNPs based on the conjunction FDR and removed SNPs in LD r 2 > 0 2 with any higher ranked SNP.
NeuroX data
We replicated the top conjunction FDR loci, highly associated with both PD and immune mediated disorders, in a second independent PD dataset. The dataset was generated with the NeuroX exome array 7, 8 including 6,927 PD cases and 6,108 controls. Variants passing standard QC (Hardy Weinberg equilibrium p value > 1 x 10 6 and maximum missingness rate of 5%) were tested for association to PD with a logistic model correcting for the first 4 MDS components and gender.
Gene expression and methylation changes influenced by top loci
We investigated data from the North American Brain Expression Consortium (NABEC), and the United Kingdom Brain Expression Consortium (UKBEC) to determine the expression and methylation levels of genes in close proximity to our top SNPs in the human frontal cortex (FCTX) and cerebellum (CRBLM). Frozen frontal cortex and cerebellar samples were obtained from 396 self reported European ancestry samples without neuropathological evidence of disease (for details see 9 11 ). The methylation analyses were based on a subset of 288 NABEC samples. In brief, we determined the regional methylation and expression patterns within +/ 1MB of 103 SNPs of interest. Methylation status was measured with the HumanMethylation27 Beadchips (Illumina). Gene expression levels were determined by either HumanRef 8
Expression Beadchips (Illumina) for the NABEC samples or GeneChip Human Exon 1.0 ST (Affymetrix) for the UKBEC samples. A total of 100 variants (3 variants not testable) were tested against 1617 traits (2 assay types in 2 tissues) which resulted in 9,198 tests. A significant cutoff was determined from a FDR at 1%
generating a significance level of p = 8 816e 05. Linear regression models were utilized to estimate associations between allele dosages per SNP and gene expression or methylation levels adjusted for gender, age at death, the first twelve component vectors from multi dimensional scaling, post mortem interval (PMI), brain bank and batch in which preparation or hybridization were performed, using MACH2QTLv1.11 (http://www.sph.umich.edu/csg/abecasis/MaCH/ download/). Furthermore, a second eQTL dataset of the frontal cortex of 119 NABEC samples was accessed. 12 The expression of the genes was determined by a cap analysis of gene expression (CAGE) technique, which allows for transcript specific eQTL analysis instead of overall gene expression eQTL analysis (for details see 12 ). Furthermore, in addition to the mRNAs identified with microarray techniques, CAGE identifies long non coding RNAs and undefined mRNAs.
© 2017 American Medical Association. All rights reserved.
A total of 83 loci (20 variants not testable) were tested. Again, traits in cis with the loci of interest were tested and results were significant at a FDR of 1%, while correcting for the covariates age, RIN value, PMI and gender.
Genetic relationships among implicated loci
To investigate the genetic relatedness among implicated SNPs, we performed two sets of analyses. First, we performed protein protein interaction analyses using STRING v10. 13 The input consisted of a list of known PD genes, 14 and novel loci as identified in pleiotropic analyses. We considered total scores above 0 400
(medium confidence) that correspond to the combination of 4 different scores: co expression, experimental, knowledge and text mining.
